Center-Authored Papers

Filters: Author is Gale, Robert P  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
2009
2011
2013
Adolescent
Adult
Aged
Tefferi A, Verstovsek S, Barosi G, Passamonti F, Roboz GJ, Gisslinger H, Paquette RL, Cervantes F, Rivera CE, Deeg HJ et al..  2009.  Pomalidomide is active in the treatment of anemia associated with myelofibrosis.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(27):4563-9. Abstract
Aged, 80 and over
Tefferi A, Verstovsek S, Barosi G, Passamonti F, Roboz GJ, Gisslinger H, Paquette RL, Cervantes F, Rivera CE, Deeg HJ et al..  2009.  Pomalidomide is active in the treatment of anemia associated with myelofibrosis.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(27):4563-9. Abstract
Anemia
Tefferi A, Verstovsek S, Barosi G, Passamonti F, Roboz GJ, Gisslinger H, Paquette RL, Cervantes F, Rivera CE, Deeg HJ et al..  2009.  Pomalidomide is active in the treatment of anemia associated with myelofibrosis.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(27):4563-9. Abstract
August 2013
Center-Authored Paper
Clinical Research Division
Michaelis LC, Saad A, Zhong X, Le-Rademacher J, Freytes CO, Marks DI, Lazarus HM, Bird JM, Holmberg L, Kamble RT et al..  2013.  Salvage Second Hematopoietic Cell Transplantation in Myeloma.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
Tefferi A, Verstovsek S, Barosi G, Passamonti F, Roboz GJ, Gisslinger H, Paquette RL, Cervantes F, Rivera CE, Deeg HJ et al..  2009.  Pomalidomide is active in the treatment of anemia associated with myelofibrosis.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(27):4563-9. Abstract
Double-Blind Method
Tefferi A, Verstovsek S, Barosi G, Passamonti F, Roboz GJ, Gisslinger H, Paquette RL, Cervantes F, Rivera CE, Deeg HJ et al..  2009.  Pomalidomide is active in the treatment of anemia associated with myelofibrosis.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(27):4563-9. Abstract
Female
Follow-Up Studies